Sugi Predict

Sugi Predict / Compounds / SCHEMBL4175335

SCHEMBL4175335

SCHEMBL4175335

COc1ccc(Nc2ccc(-c3coc4cc(O)ccc4c3=O)cc2)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.86
▸ ALDH1A1 P00352 8/20 0.86
▸ MAPT P10636 7/20 0.86
▸ HSD17B10 Q99714 6/20 0.86
▸ HPGD P15428 6/20 0.86
▸ SMN1; SMN2 Q16637 6/20 0.86
▸ MAOA P21397 6/20 0.86
▸ MAOB P27338 6/20 0.86
▸ TP53 P04637 5/20 0.86
▸ CYP3A4 P08684 5/20 0.86
▸ MEN1 O00255 4/20 0.86
▸ KMT2A Q03164 4/20 0.86
▸ CYP2D6 P10635 3/20 0.86
▸ CYP2C9 P11712 3/20 0.86
▸ CYP2C19 P33261 3/20 0.86
▸ HDAC6 Q9UBN7 2/20 0.86
▸ CYP1B1 Q16678 2/20 0.86
▸ BCL2 P10415 1/20 0.86
▸ IL2 P60568 1/20 0.86
▸ XDH P47989 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formononetin SCHEMBL15271536 0.93 KDM4E (1.00) KDM4EALDH1A1MAPTHSD17B10HPGD
Formononetin SCHEMBL29361145 0.93 KDM4E (1.00) KDM4EALDH1A1MAPTHSD17B10HPGD
Formononetin SCHEMBL62915 0.93 KDM4E (1.00) KDM4EALDH1A1MAPTHSD17B10HPGD
Formononetin SCHEMBL6638953 0.92 KDM4E (0.97) KDM4EALDH1A1MAPTHSD17B10HPGD
Formononetin SCHEMBL8416577 0.92 KDM4E (0.97) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL4173475 0.85 KDM4E (0.78) KDM4EALDH1A1MAPTHSD17B10HPGD
Isoformonentin SCHEMBL30105310 0.85 XDH (1.00) KDM4EALDH1A1MAPTHSD17B10HPGD
Isoformonentin SCHEMBL73338 0.85 XDH (1.00) KDM4EALDH1A1MAPTHSD17B10HPGD
Formononetin SCHEMBL247496 0.85 KDM4E (0.84) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL4191801 0.84 KDM4E (0.67) KDM4EALDH1A1MAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192152-A1 Novel Antigiardial Agents and Methods of Use Thereof UNIVERSITY OF MISSISSIPPI 2009-07-30 — — US disclosed
US-20090192152-A1 Novel Antigiardial Agents and Methods of Use Thereof UNIVERSITY OF MISSISSIPPI 2009-07-30 — — US disclosed
US-7468445-B2 Antigiardial agents and use thereof UNIVERSITY OF MISSISSIPPI (US) 2008-12-23 — — US disclosed
US-7468445-B2 Antigiardial agents and use thereof UNIVERSITY OF MISSISSIPPI (US) 2008-12-23 — — US disclosed
US-20060106091-A1 Antigiardial agents and use thereof THE UNIVERSITY OF MISSISSIPPI 2006-05-18 — — US disclosed
WO-2004014886-A1 ANTIGIARDIAL AGENTS AND USE THEREOF UNIVERSITY OF MISSISSIPPI (US) 2004-02-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106091-A1 Antigiardial agents and use thereof GPER1, ENPP2, ALPI KDM4E 2433/4885ALDH1A1 2026/4885MAPT 4607/4885
US-20090192152-A1 Novel Antigiardial Agents and Methods of Use Thereof ENPP2, GPER1, ALPI KDM4E 2954/4885ALDH1A1 2472/4885MAPT 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.